Will Southern s Patent Blot Out Affymetrix? | GenomeWeb

Struggling array-makers eagerly await the October 31 jury trial for Oxford Gene Technology’s patent infringement suit against Affymetrix. Oxford is seeking $300 million in damages, an injunction, and/or royalties. Regarding its Delaware court date, Affy will say only that the patent in question is just one of many covering arrays.

But this particular patent seems to be special: Agilent and Incyte have negotiated licenses and Affy has tried twice to acquire one.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.